Vijaya Diagnostic Centre Limited has informed the Exchange regarding a revised press release dated July 28, 2025, titled "Financial Results for Q1 FY 2026".
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vijaya Diagnostic Centre reported strong Q1 FY26 results with consolidated revenue from operations of Rs 1,880.5 million, up 20.4% year-on-year from Rs 1,562.2 million in Q1 FY25, and up 8.6% sequentially from the previous quarter. EBITDA grew 20.1% YoY to Rs 735.3 million, with margins largely flat at 39.1%. Profit after Tax rose 22.3% YoY to Rs 383.4 million, with PAT margin expanding to 20.4% from 20.1%. Operational metrics were also healthy, with total tests up 16.7% to 3.94 million, footfall up 14.4% to 1.10 million, and average realisation per test rising 3.1% to Rs 477. The company highlighted that its Hyderabad market returned to double-digit growth and that new hubs in Pune, Bengaluru, and West Bengal are now operational, with Nizamabad hub achieving break-even within two quarters.
Strong double-digit revenue and profit growth, combined with margin expansion, signals healthy business momentum and should be viewed positively by shareholders. The outlook of commissioning more hubs in the coming quarters points to continued growth, though investors should watch for margin pressures as newer centres ramp up.